Moreover, the proportion of high sarcosine type [GNMT(+)/SARDH and PIPOX(-)] was highest in HER-2 type tumors, suggesting that sarcosine levels are higher in HER-2 type breast cancers than in other molecular subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.